Join to View Full Profile
Dana-Farber Cancer Institute450 Brookline AveBoston, MA 02215
Dr. Strickland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2023
Dana-Farber Cancer InstituteOncology, 2023
Boston University Medical CenterResidency, Internal Medicine, 2016 - 2019
Boston University School of MedicineClass of 2016
Certifications & Licensure
MA State Medical License 2016 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Development of a fibrin-targeted theranostic for gastric cancer.Shadi A Esfahani, Li Ma, Shriya Krishna, Hua Ma, Shvan J Raheem
Science Translational Medicine. 2024-12-11 - 1 citationsDevelopment of a streamlined NGS-based TCGA classification scheme for gastric cancer and its implications for personalized therapy.Pengda Guo, Yang Yang, Lu Wang, Yu Zhang, Bei Zhang
Journal of Gastrointestinal Oncology. 2024-10-31 - Dual HER2 inhibition: Is two better than one?Matthew R Strickland, Samuel J Klempner
Med. 2024-10-11
Press Mentions
More Than 75% of Oncologists in Some Communities Are Not Ordering Biomarker Testing Per GuidelinesFebruary 11th, 2025- Managing Defective Mismatch Repair in Gastroesophageal AdenocarcinomaMay 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
